DanCann Pharma (DANCAN)

DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.

Quotes for DanCann Pharma A/S

Right Now

+/-: -0.11
%: −8,33%
Latest: 1.21
High: 1.69
Low: 1.21
Volume: 48 154
Turnover (DKK): 66 254
Market Value (MDKK): 4,8
Time (Latest trade): 2025-04-10 16:59

Board

CEO

Jeppe Krog Rasmussen

Chairperson of the Board

Carsten Trads

Board

Jeppe Krog Rasmussen
Christian Carlsen
Jes Lunde

News

2025-04-04 17:50:00 DanCann Pharma A/S: Notice of Annual General Meeting in DanCann Pharma A/S
2025-04-04 17:45:00 DanCann Pharma A/S Releases 2024 Annual Report Highlighting Growth and Operational Efficiency
2025-03-27 20:00:00 DanCann Pharma A/S: Postponement of release of annual report 2024 and AGM 2025
2025-03-13 13:00:00 DanCann Pharma A/S forges cutting edge alliance with Tetra Pharm Technologies ApS
2025-02-18 14:15:00 DanCann Pharma A/S: Completion of reverse share split and redemption of shares

News agencies

2025-03-13 13:31:57 Finwire: Dancann Pharma ingår partnerskap med Tetra Pharm Technologies
2025-02-24 10:57:19 Finwire: Handeln i Dancann Pharmas aktie återupptas
2025-02-24 09:27:30 Finwire: Dancann Pharma handelsstoppas - handlas efter omvänd split idag
2025-02-18 14:20:26 Finwire: Dancann Pharma handlas den 24 februari efter omvänd split 1:1 000
2025-02-17 08:32:06 Finwire: Dancann Pharma rapporterar lägre omsättning och minskad förlust

Analysis

Largest Owners

Name	Capital %	Votes %	Date
JEQ Capital AB	10,42	10,42	2024-11-25
Niklas Estensson	4,20	4,20	2024-11-25
Robert Burén	4,20	4,20	2024-11-25
Alexander Schoeneck	3,83	3,83	2024-11-25
Erik Lundin	3,15	3,15	2024-11-25
Johan Alexander Kangas	2,52	2,52	2024-11-25
Nils Berg	2,52	2,52	2024-11-25
Love Carlsson	2,52	2,52	2024-11-25
Andreas Poike	2,10	2,10	2024-11-25
Jonas Hagberg med bolag	2,10	2,10	2024-11-25

Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

DanCann Pharma A/S